Amerise Biosciences Ltd (BSE: 531681) is an Ahmedabad, Gujarat-based company in the Shell and Dormant Entities industry. With a market capitalisation of ₹5 Cr, it ranks #4,983 by market cap among the 6,197 Indian listed companies on FinBizNet, and #7 of 10 in Shell and Dormant Entities. At ₹0.86 (as of 16 Nov 2026), the share price is 16.5% below its 52-week high of ₹1.03 and 72.0% above its 52-week low of ₹0.50. The share price is up 33.8% over one year and up 2.4% over three months.
| Current Price | ₹0.86 |
|---|---|
| Market Cap | ₹5 Cr |
| BSE Code | 531681 |
| Sector | Industrials > Capital Goods > Trading Companies and Distributors |
| Sub-Industry | Diversified Support Services > Shell and Dormant Entities |
| P/E Ratio | 435 |
| Return on Equity | 0.30% |
| Return on Assets | 0.16% |
| 52-Week Range | ₹0.50 – ₹1.03 |
| 1-Year Price Change | +33.8% |
| 3-Month Price Change | +2.4% |
| Beta (1Y) | 0.59 |
| Headquarters | Ahmedabad, Gujarat |
| Website | www.amerisebiosciencesltd.life |
Delivery averaged 95.4% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).
Amerise Biosciences Limited does not have significant operations. Previously, it was involved in the commodity trading business. The company was formerly known as Amradeep Industries Limited and changed its name to Amerise Biosciences Limited in December 2021. The company was incorporated in 1984 and is based in Ahmedabad, India.
1. Unclassified Services-This segment engages in commodity trading business in India.
1. Unclassified Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Milgrey Finance & Investments Ltd | ₹84 Cr | n/m | -0.01% | ₹0 Cr | -47.3% |
| Regis Industries Ltd | ₹53 Cr | 71.4 | 2.85% | — | -30.8% |
| Salem Erode Investments Ltd | ₹45 Cr | n/m | -28.58% | — | -52.8% |
| Johnson Pharmacare Ltd | ₹25 Cr | n/m | -1.97% | — | -27.0% |
| Triumph International Finance India | ₹13 Cr | — | — | — | -42.4% |
| Amraworld Agrico Ltd. | ₹6 Cr | n/m | -9.87% | — | -38.6% |
| Amerise Biosciences Ltd | ₹5 Cr | 435 | 0.30% | — | +33.8% |
| Saianand Commercial Ltd | ₹5 Cr | 27.5 | 0.43% | — | -27.3% |
| B. P. Capital Ltd | ₹0 Cr | n/m | -3.80% | — | +35.2% |
Listed by market capitalisation. Ratios are shown for context only.
Amerise Biosciences Ltd is trading at ₹0.86, with a market capitalisation of ₹5 Cr.
Amerise Biosciences Ltd operates in the Industrials > Capital Goods > Trading Companies and Distributors space (Diversified Support Services > Shell and Dormant Entities).
Amerise Biosciences Ltd has a P/E of 435 and a return on equity of 0.30%.
Amerise Biosciences Ltd is listed on the BSE under the scrip code 531681.
Amerise Biosciences Ltd's share price is up 33.8% over one year and up 2.4% over three months. Its 52-week range is ₹0.50 to ₹1.03.
Data as of 16 Nov 2026. Descriptive market data only — not investment advice.